Accéder au contenu
Merck

Discovery of potent non-urea inhibitors of soluble epoxide hydrolase.

Bioorganic & medicinal chemistry letters (2009-03-24)
Yuli Xie, Yidong Liu, Gangli Gong, Deborah H Smith, Fang Yan, Alison Rinderspacher, Yan Feng, Zhengxiang Zhu, Xiangpo Li, Shi-Xian Deng, Lars Branden, Dusica Vidović, Caty Chung, Stephan Schürer, Christophe Morisseau, Bruce D Hammock, Donald W Landry
RÉSUMÉ

Soluble epoxide hydrolase (sEH) is a novel target for the treatment of hypertension and vascular inflammation. A new class of potent non-urea sEH inhibitors was identified via high throughput screening (HTS) and chemical modification. IC(50)s of the most potent compounds range from micromolar to low nanomolar.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Methyl isonipecotate, technical grade